Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4179.80 +0.2% SILVER 57.50 +0.6% COPPER 6.63 +1.1% OIL 95.91 −2.1% PALLADIUM 1129.25 +0.1% BUFF 0.780 +0.0% FEO 0.650 +0.0% LIB 0.720 +0.0% NPR 0.620 +0.0% QZM 0.380 +0.0% BVA 0.760 +0.0% ONAU 0.520 +0.0% FMR 0.225 +0.0% GSVR 0.340 +0.0% PHNM 0.340 +0.0% SLG 5.71 +0.0% CASA 0.060 +0.0% DRY 0.215 +0.0% SOMA 0.560 +0.0% PWRO 0.025 +0.0% OMI 0.250 +0.0% GOLD 4179.80 +0.2% SILVER 57.50 +0.6% COPPER 6.63 +1.1% OIL 95.91 −2.1% PALLADIUM 1129.25 +0.1% BUFF 0.780 +0.0% FEO 0.650 +0.0% LIB 0.720 +0.0% NPR 0.620 +0.0% QZM 0.380 +0.0% BVA 0.760 +0.0% ONAU 0.520 +0.0% FMR 0.225 +0.0% GSVR 0.340 +0.0% PHNM 0.340 +0.0% SLG 5.71 +0.0% CASA 0.060 +0.0% DRY 0.215 +0.0% SOMA 0.560 +0.0% PWRO 0.025 +0.0% OMI 0.250 +0.0%

Healthcare

Page 54
  1. Mar 03, 2026 · 16:29 · VPT

    Ventripoint signs LG deal to support VMS+ rollout

    Ventripoint signs LG deal to support VMS+ rollout

    01
  2. Mar 03, 2026 · 16:19 · AIDR

    Rocket Doctor expands NY access with insurer contract

    Rocket Doctor expands NY access with insurer contract

    02
  3. Mar 03, 2026 · 08:01 · PHRM

    PharmaTher Expands PharmaPatch Delivery Platform into Therapeutic Peptides for the U.S. Market

    PharmaTher Expands PharmaPatch Delivery Platform into Therapeutic Peptides for the U.S. Market

    03
  4. Mar 03, 2026 · 08:00 · AIDR

    Rocket Doctor Signs New Contract with Major U.S. Insurer, Expanding Access to an Additional 2.4 Million Members Across New York State

    Rocket Doctor Signs New Contract with Major U.S. Insurer, Expanding Access to an Additional 2.4 Million Members Across New York State

    04
  5. Mar 03, 2026 · 08:00 · VPT

    Ventripoint Diagnostics Ltd. Signs Commercial Agreement with LG Consulting Solutions to Support VMS+ Deployment in Northern California

    Ventripoint Diagnostics Ltd. Signs Commercial Agreement with LG Consulting Solutions to Support VMS+ Deployment in Northern California

    05
  6. Mar 02, 2026 · 21:07 · RX

    BioSyent closes Oral Science acquisition, grants RSUs

    BioSyent closes Oral Science acquisition, grants RSUs

    06
  7. Mar 02, 2026 · 17:15 · TLT

    Theralase's data point to enhanced cancer cell kill

    Theralase's data point to enhanced cancer cell kill

    07
  8. Mar 02, 2026 · 16:00 · VTAL

    Justera Announces Definitive Agreement to Sell Port North Extracts Inc. and Resignations

    Justera Announces Definitive Agreement to Sell Port North Extracts Inc. and Resignations

    08
  9. Mar 02, 2026 · 08:30 · RX

    BioSyent Announces Closing of the Acquisition of Oral Science Inc.

    BioSyent Announces Closing of the Acquisition of Oral Science Inc.

    09
  10. Mar 02, 2026 · 08:30 · DHT

    DRI Healthcare Trust Announces Preferred Securities Refinancing

    DRI Healthcare Trust Announces Preferred Securities Refinancing

    10
  11. Mar 02, 2026 · 07:01 · TLT

    Light-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy

    Light-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy

    11
  12. Mar 01, 2026 · 21:00 · ONCO

    FutureGen Industries Provides Investment Performance Update and Shares Realized Gains

    FutureGen Industries Provides Investment Performance Update and Shares Realized Gains

    12
  13. Feb 27, 2026 · 20:41 · DTC

    Defence Therapeutics arranges $11-million financing

    Defence Therapeutics arranges $11-million financing

    13
  14. Feb 27, 2026 · 20:18 · NVRS

    Noveris convertible debenture acquired by JJK Holdings

    Noveris convertible debenture acquired by JJK Holdings

    14
← Newer Older →